Big Flats, NY – (August, 2013) - X-GEN Pharmaceuticals, Inc. announces FDA approval to begin marketing and distributing Tranexamic Acid Injection. Tranexamic Acid is the generic product AP rated to Cyklokapron® and works by blocking the breakdown of blood clots in hemophiliacs. Tranexamic Acid reduces or prevents hemorrhage and can also minimize the potential need [...]
Big Flats, NY – (June 14, 2013) - X-GEN Pharmaceuticals, Inc. today announced that it is a winner of the first Legacy Award, presented by the Premier healthcare alliance. Premier, a provider-owned performance improvement alliance of 2,800 hospitals and nearly 100,000 other care sites, contracts with more than 1,000 suppliers. X-GEN is one of 18 [...]
